Select Equity Group
BIO icon

Select Equity Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Select Equity Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-48,436
Closed -$13.5M – 158
2026
Q1 		$13.5M Buy
+48,436
New +$13.9M 0.07% 124
2025
Q3 		– Sell
-255,989
Closed -$61.8M – 169
2025
Q2 		$61.8M Sell
255,989
-9,191
-3% -$2.17M 0.26% 68
2025
Q1 		$64.6M Sell
265,180
-195,478
-42% -$58.8M 0.28% 62
2024
Q4 		$151M Sell
460,658
-247,794
-35% -$84.1M 0.6% 48
2024
Q3 		$237M Buy
708,452
+58,930
+9% +$18.7M 0.85% 37
2024
Q2 		$177M Buy
649,522
+134,856
+26% +$39.2M 0.7% 39
2024
Q1 		$178M Buy
514,666
+322,242
+167% +$106M 0.63% 42
2023
Q4 		$62.1M Buy
192,424
+134,798
+234% +$42.2M 0.22% 70
2023
Q3 		$20.7M Sell
57,626
-42,954
-43% -$16.6M 0.08% 102
2023
Q2 		$38.1M Buy
+100,580
New +$40.9M 0.14% 92
2019
Q1 		– Sell
-59,550
Closed -$13.8M – 98
2018
Q4 		$13.8M Sell
59,550
-127,373
-68% -$34.2M 0.1% 84
2018
Q3 		$58.5M Buy
186,923
+142,604
+322% +$44.3M 0.43% 54
2018
Q2 		$12.8M Buy
+44,319
New +$12.2M 0.1% 82
2017
Q1 		– Sell
-46,174
Closed -$8.42M – 92
2016
Q4 		$8.42M Sell
46,174
-20,367
-31% -$3.47M 0.07% 84
2016
Q3 		$10.9M Sell
66,541
-17,224
-21% -$2.61M 0.09% 89
2016
Q2 		$12M Sell
83,765
-2,109
-2% -$301K 0.11% 87
2016
Q1 		$11.7M Buy
85,874
+44,031
+105% +$5.78M 0.1% 84
2015
Q4 		$5.8M Sell
41,843
-8,717
-17% -$1.21M 0.06% 100
2015
Q3 		$6.79M Sell
50,560
-15,500
-23% -$2.23M 0.06% 100
2015
Q2 		$9.95M Sell
66,060
-41,038
-38% -$5.87M 0.09% 92
2015
Q1 		$14.5M Sell
107,098
-98,134
-48% -$12.2M 0.13% 88
2014
Q4 		$24.7M Buy
+205,232
New +$23.6M 0.23% 72

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Select Equity Group's BIO Position: Q2 2026 in Review

Select Equity Group sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 48,436 shares — an estimated $13.5M sold.

Select Equity Group first reported a position in BIO in Q4 2014 and held it in 22 quarters. The position peaked at $237M in Q3 2024. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Select Equity Group reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Select Equity Group sold 48,436 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $13.5M.
  • Select Equity Group first reported a position in Bio-Rad Laboratories Class A in Q4 2014 and held it in 22 quarters.
  • Select Equity Group's Bio-Rad Laboratories Class A position peaked at $237M in Q3 2024.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Select Equity Group's 13F filing for Q2 2026, filed 14 Aug 2026.